<?xml version="1.0" encoding="UTF-8"?>
<p id="Par24">The questionnaire consisted of three parts: (a) comprehensibility of consent-form, (b) research risk appraisal and notions of therapeutic misconception and (c) assessment of motivational issues.
 <list list-type="alpha-lower">
  <list-item>
   <p id="Par25">The first part comprised nine elements related to the template consent-form: its perceived length and subjective general comprehensibility were to be evaluated via Likert-scaled items, linked with two open questions allowing for personal criticism or concerns. Five multiple choice questions were utilised to test participants’ understanding of major components of informed consent (right to have a say, right to withdraw, purpose of the study, allocation of placebo and personal gain derived from study participation) as understood from the consent form.</p>
  </list-item>
  <list-item>
   <p id="Par26">The questionnaire’s second part was interrogative, with four statement items focusing on risk appraisal and therapeutic misconception [
    <xref ref-type="bibr" rid="CR16">16</xref>]. For each statement, participants were asked to choose one of three to five possible answers (multiple choice format).
   </p>
  </list-item>
  <list-item>
   <p id="Par27">The third part comprised 19 Likert-scaled items assessing the motivational power of the opinions of particpants’ parents, doctors, and friends, as well as potential influencing factors such as painfulness, material incentives, pro-social reasons and data security.</p>
  </list-item>
 </list>
</p>
